Prasol Chemicals IPO Review: 84% OFS, 48x FY26
A speciality-chemicals maker is raising ₹500 crore, 84% of it an OFS, at 48x FY26. Margins doubled; cash did not keep up. Here are the five checks.
By AlphaResearch · 8 Sept 2026 · 10 min read
AARTIINDATULVINATIORGA
Issue snapshot
| Company | Prasol Chemicals Ltd — prasolchem.com | ||
|---|---|---|---|
| Issue size | ₹500 crore | Price band | ₹643–₹676 |
| Fresh issue | ₹80.00 crore | Offer for sale | ₹420 crore |
| Lot size | 22 shares | Exchange | NSE |
| Bidding | 8–10 Sept 2026 | Listing | 16 Sept 2026 |
Company: Prasol Chemicals Ltd · Navi Mumbai · acetone- and phosphorus-based speciality chemicals, exports to 60+ countries · mainboard IPO, NSE and BSE
Key takeaways
- IssueThe book is ₹500 crore: ₹80 crore fresh (₹60 crore to repay debt), ₹420 crore OFS — 84% of the issue.
- FinancialsRevenue from operations rose ₹876.56 crore → ₹1,012.49 crore → ₹1,232.59 crore; PAT ₹18.13 → ₹43.57 → ₹83.12 crore. EBITDA margin 6.91% → 11.30%.
- Cash flowOperating cash was ₹115.61 crore in FY24 and only ₹49.47 crore in FY26 — profit grew faster than cash.
- ValuationAt ₹676, post-issue mcap is about ₹4,001 crore, or 48.1x FY26 and 91.9x FY25.
- PeersNamed peers on 3 Sep 2026: Excel Industries 18.2x, Vinati Organics 27.3x, Aarti Industries 34.8x.
- DemandDay 1 closed (8 Sep, 18:54 IST) at 0.44x overall: retail 0.74x, NII 0.33x, QIB ex-anchor nil. Anchors put in ₹150 crore on 7 Sep. The unofficial GMP was ₹85 on 8 Sep, down from ₹120 on 7 Sep; CNBC-TV18 quoted ₹55 (~8%) — unofficial, unregulated, often wrong.
The deal in one paragraph
Prasol is a 1992 speciality-chemicals manufacturer with 150-plus acetone and phosphorus products and an export book. Coverage calls it India’s only isophorone maker. The three-year margin expansion is in the abridged prospectus, not in a broker’s adjective. The offer still asks 48 times that year, after a year when cash from operations was less than half of FY24, and 84% of the ₹500 crore is a sale by existing holders. Niche is not a multiple. The first day of bidding did not cover the book, and the grey market gave back a third of its premium in one session. Our verdicts are avoid for listing gains and avoid for a long-term hold at ₹676; the reasoning is below.
Data
Issue structure
| Item | Figure | Units |
|---|---|---|
| Total issue | 500 | ₹ cr |
| Fresh issue | 80 | ₹ cr |
| OFS | 420 | ₹ cr |
| Price band | 643–676 | ₹ / share |
| Lot | 22 | shares (₹14,872 at the cap) |
| Pre / post shares | 5.80 / 5.92 | cr |
| Debt repayment from fresh | 60 | ₹ cr |
| Listing (tentative) | 16 Sep 2026 | NSE + BSE |
Source: Paytm Money; CNBC-TV18. Tickers named above are listed peers used for comparison, not recommendations.
₹80 crore in, ₹420 crore out; the largest single use of the fresh money is debt repayment.
Financials (restated, ₹ cr)
| FY24 | FY25 | FY26 | |
|---|---|---|---|
| Revenue from operations | 876.56 | 1,012.49 | 1,232.59 |
| Operating EBITDA | 60.53 | 87.77 | 139.32 |
| EBITDA margin | 6.91% | 8.67% | 11.30% |
| PAT | 18.13 | 43.57 | 83.12 |
| PAT margin | 2.07% | 4.30% | 6.74% |
| Operating cash flow | 115.61 | 22.26 | 49.47 |
| Borrowings | 82.07 | 101.05 | 110.06 |
| EPS (₹) | 3.13 | 7.51 | 14.33 |
| NAV (₹) | 56.18 | 63.35 | 77.33 |
Units: ₹ crore except per-share figures and margins. Source: SEBI abridged prospectus. IPO Watch flags commitments of ₹99.11 crore and contingent liability ₹10.02 crore as of 31 Mar 2026.
PAT margin moved from 2.07% to 6.74%; the bars show how thin the profit line still is against revenue.
FY26 operating cash (₹49.47 crore) is less than half of FY24 and below FY26 PAT.
Valuation at the upper band
| Metric | At ₹676 |
|---|---|
| Post-issue mcap (derived) | ~₹4,001 cr |
| P/E FY26 | 48.1x |
| P/E FY25 | 91.9x |
| P/B on NAV ₹77.33 | 8.74x |
| Aarti Industries P/E (3 Sep) | 34.8x |
| Vinati Organics P/E | 27.3x |
| Atul P/E | 24.0x |
| Excel Industries P/E | 18.2x |
Units: rupees crore and times. Source: IPO Watch peer table dated 3 Sep 2026; mcap derived from Paytm Money post-issue share count × ₹676.
Every named peer trades below the IPO multiple; the FY25 bar shows what the price looks like on the year before margins doubled.
Subscription and unofficial GMP
Subscription by category, day 1 of 3 (book 8–10 Sep 2026):
| Category | Shares offered | 8 Sep, early day-1 prints | 8 Sep 18:54 IST, day-1 close (Chittorgarh) |
|---|---|---|---|
| QIB ex-anchor | 14,79,289 | — | no bids reported |
| NII | 11,09,466 | — | 0.33x |
| Retail | 25,88,753 | — | 0.74x |
| Overall (ex-anchor) | — | ~0.14x | 0.44x |
Units: times subscribed (x) on shares offered ex-anchor. Source: early prints as cited on 8 Sep; Chittorgarh (NSE + BSE data). Chittorgarh lists no QIB row for the day, which on its tables means no bids in the category.
Anchor book (7 Sep 2026, Chittorgarh): ₹150 crore for 22,18,930 shares at ₹676 — 30% of the issue — across 14 allottees. The largest lines were Aditya Birla Sun Life Insurance (₹20 crore), Tata AIA Life's Small Cap Discovery Fund (₹20 crore), Turnaround Opportunities Fund (₹15 crore), ITI Small Cap Fund (₹15 crore), Clarus Capital I (₹11.99 crore), and ₹10 crore each from Tata India Pharma & Healthcare, Tata India Innovation, Edelweiss Aggressive Hybrid and Nuvama Multi Asset Strategy; three Kotak Mahindra Mutual Fund schemes took ₹7.97 crore or less apiece. Half the anchor shares are locked for 30 days, half for 90.
Unofficial grey-market premium over ₹676 (IPO Watch, updated 17:45 IST daily): ₹14 on 3 and 4 Sep, ₹120 on 7 Sep, ₹85 on 8 Sep (~12.6%). CNBC-TV18 quoted ₹55 (~8%) on 8 Sep. Grey-market premiums are informal and often wrong; I do not treat them as a listing forecast.
Risks
- 84% OFS. ₹80 crore in, ₹420 crore out.
- 48x on the year margins doubled; 92x on the year before.
- Cash lagged profit. FY26 OCF is below FY24.
- Plant-shutdown risk on a manufacturing book (broker notes via CNBC-TV18).
- Acetone / phosphorus input cycle.
- Commitments near ₹99 crore against an ₹80 crore fresh issue.
AlphaResearch verdict
At ₹676 — Listing gains: Avoid · Long-term hold: Avoid. Two applicants, two calls, and on this issue they agree. The demand read is for the applicant who intends to sell on or after listing; the five checks are for the one who intends to hold.
For listing gains
The first day did not cover the book: 0.44x overall at the 18:54 IST close, with retail at 0.74x, NII at 0.33x and no QIB bids beyond the anchor round. The ₹150 crore anchor book is 30% of the issue and carries Aditya Birla Sun Life Insurance, Tata AIA, Tata Mutual Fund, ITI and Kotak Mahindra Mutual Fund lines — respectable names, but at ₹5–20 crore each and with no follow-through on day 1. The unofficial grey-market premium gave back a third of itself in one session, ₹120 to ₹85, and the CNBC-TV18 print was ₹55; it is unregulated and often wrong in both directions. Allotment odds are not the constraint here — an under-covered book allots in full — demand is. On this evidence a listing application is a bet on day 3 rescuing the book, and that is not a verdict we can stand behind: Listing gains: Avoid.
- Anchor book · Partial₹150 crore, 14 allottees; ABSLI and Tata AIA ₹20 crore each, ITI ₹15 crore, Kotak MF and Tata MF lines of ₹10 crore or less.
- QIB demand · FailsNo QIB bids reported beyond the anchor round at the day-1 close (8 Sep 18:54 IST).
- NII demand · Fails0.33x at the day-1 close.
- Retail demand · Fails0.74x at the day-1 close; book not covered.
- Grey market (unofficial) · Partial₹85 (~12.6%) on 8 Sep, down from ₹120 on 7 Sep; CNBC-TV18 print ₹55; unofficial, unregulated, often wrong.
Demand evidence as of the 8 Sep close. Not a listing-price forecast.
For a long-term hold
Long-term hold: Avoid at ₹676. Clears 1 of 5 checks (business). Numbers are partial. Price and OFS fail.
- Business · Clears150-plus acetone and phosphorus products; exports to 60+ countries; documented margin expansion 6.91% → 11.30%.
- Numbers · PartialPAT ₹18.13 → ₹83.12 crore, but operating cash fell from ₹115.61 crore (FY24) to ₹49.47 crore (FY26).
- Price · Fails48.1x FY26 vs Aarti 34.8x, Vinati 27.3x, Atul 24.0x, Excel 18.2x; 91.9x on FY25.
- Structure · Fails₹420 crore of ₹500 crore (84%) is an OFS; ₹60 crore of the ₹80 crore fresh goes to debt repayment.
- Red flags · FailsCommitments ₹99.11 crore against an ₹80 crore fresh issue; input-cycle and plant-shutdown risk.
Why: the product niche and the three-year margin expansion are real and documented in the abridged prospectus. The offer still asks 48 times that year after operating cash fell to less than half of FY24, and 84% of the ₹500 crore is existing holders selling. Niche is not a multiple, and a shrinking cash conversion in the year you are being asked to pay up is the wrong direction.
What flips this verdict — listing gains: overall subscription above 3x at the 10 Sep close with NII above 5x and QIB ex-anchor covered, and the unofficial GMP holding at or above ₹85, moves the listing call to Neutral. Nothing short of that does.
What flips this verdict — long-term hold: two quarters holding EBITDA margin at or above 11% with operating cash at least matching PAT moves us to Neutral. A live price nearer the Vinati / Aarti multiples on FY26 earns a full re-read.
Dates: book closes 10 Sep; allotment 11 Sep; listing tentatively 16 Sep 2026.
A companion video is planned; numbers will come only from this article and docs/ipo_analysis/prasol_chemicals.md.
Position disclosure: none. AARTIIND, ATUL and VINATIORGA appear only as listed-peer comparables.
Sources
- SEBI abridged prospectus, restated financials (accessed 8 Sept 2026)
- Paytm Money, issue table and objects (accessed 8 Sept 2026)
- IPO Watch, P/E 48.11x and peer P/Es 3 Sep 2026 (accessed 8 Sept 2026)
- CNBC-TV18, unofficial GMP ₹55 and objects (accessed 8 Sept 2026)
- Chittorgarh, Day-1 close subscription by category (8 Sep 18:54 IST) and anchor allocation (accessed 8 Sept 2026)
- IPO Watch, unofficial GMP trend to 8 Sep 17:45 IST (accessed 8 Sept 2026)